World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
186
Citations
141379
World Ranking
488
National Ranking
319

Medicine

D-Index
178
Citations
128059
World Ranking
390
National Ranking
243

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Michael J. Keating is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily spans the field of medicine, with a focus on genetics, pathology and forensic medicine, immunology, oncology, and epidemiology.

The scientist's work covers key topics including chronic lymphocytic leukemia research, lymphoma diagnosis and treatment, inflammatory bowel disease, immunodeficiency and autoimmune disorders, microscopic colitis, advanced breast cancer therapies, and liver diseases and immunity.

Michael J. Keating has contributed to several recent publications, among which are:

  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors (2020, New England Journal of Medicine)
  • Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia (2021, JAMA Oncology)
  • A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL (2022, Blood Advances)
  • AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia (2020, Clinical Cancer Research)
  • Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up (2023, Blood)

Frequent collaborators include:

  • William G. Wierda
  • Alessandra Ferrajoli
  • Nitin Jain
  • Philip A. Thompson
  • Jan A. Burger

The scientist's publications appear predominantly in journals such as:

  • Blood
  • Journal of Crohn's and Colitis
  • Leukemia
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia & lymphoma/Leukemia and lymphoma

Best Publications

  • Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

    George Adrian Calin;Calin Dan Dumitru;Masayoshi Shimizu;Roberta Bichi

  • Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment

    Bruce D. Cheson;John M. Bennett;Michael Grever;Neil Kay

  • iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    Enli Liu;David Marin;Pinaki Banerjee;Homer A. Macapinlac

  • Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

    Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien

  • Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

    I F Khouri;M Keating;M Körbling;D Przepiorka

  • Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

    Michael J. Keating;Susan O'Brien;Maher Albitar;Susan Lerner

  • CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients

    Barbara Savoldo;Carlos Almeida Ramos;Carlos Almeida Ramos;Enli Liu;Martha P. Mims

  • Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

    Michael J. Keating;Ian Flinn;Vinay Jain;Jacques-Louis Binet

  • Superoxide dismutase as a target for the selective killing of cancer cells

    Peng Huang;Li Feng;Elizabeth A. Oldham;Michael J. Keating

  • ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia

    Laura Z. Rassenti;Lang Huynh;Tracy L. Toy;Liguang Chen

  • Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

    Rui Hua Xu;Helene Pelicano;Yan Zhou;Jennifer S. Carew

  • Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

    B D Cheson;P A Cassileth;D R Head;C A Schiffer

  • Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

    Alvaro Aguayo;Hagop M Kantarjian;Taghi Manshouri;Cristi Gidel

  • Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaA in Chronic Myelogenous Leukemia

    Moshe Talpaz;Hagop M. Kantarjian;Kenneth McCredie;Jose M. Trujillo

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.

    Constantine S. Tam;Susan O'Brien;William Wierda;Hagop Kantarjian

  • Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

    Hagop Kantarjian;Deborah Thomas;Susan O'Brien;Jorge Cortes

  • Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia

    Susan M. O’Brien;Hagop Kantarjian;Deborah A. Thomas;Francis J. Giles

Frequent Co-Authors

Susan O'Brien
Susan O'Brien University of California, Irvine
William G. Wierda
William G. Wierda The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Alessandra Ferrajoli
Alessandra Ferrajoli The University of Texas MD Anderson Cancer Center
Jan A. Burger
Jan A. Burger The University of Texas MD Anderson Cancer Center
Zeev Estrov
Zeev Estrov The University of Texas MD Anderson Cancer Center
Stefan Faderl
Stefan Faderl The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Elihu H. Estey
Elihu H. Estey University of Washington
Nitin Jain
Nitin Jain The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The healthcare field offers numerous online educational options for those seeking flexible study paths and diverse career opportunities. One popular choice is the RN to BSN pathway, which helps registered nurses advance their careers with a bachelor’s degree. Prospective students often look for the average cost of rn to bsn programs to understand the investment required and to find affordable options.

For individuals without a nursing background, there are also entry level msn programs online that provide a direct route to advanced nursing roles. These fast-tracked programs can be ideal for career changers who want to enter nursing at the graduate level.

Those looking for more accessible program options may be interested in the easy nursing programs to get into, which can help students enter the medical field with fewer barriers to admission.

Not all healthcare careers require direct patient care. Some prefer the administrative side, such as medical billing and coding. There are online medical billing and coding schools that accept fafsa, making these courses more financially accessible.

Best Scientists Citing Michael J. Keating

Trending Scientists

Recently Published Articles